Dendritic spines are the site of most excitatory synapses, the loss of which correlates with cognitive impairment in patients with Alzheimer disease. Substantial evidence indicates that amyloid-A (AA) peptide, either insoluble fibrillar AA deposited into plaques or soluble nonfibrillar AA species, can cause spine loss but the concurrent contributions of fibrillar AA and nonfibrillar AA to spine loss has not been previously assessed. We used multiple-label immunohistochemistry to measure spine density, size, and F-actin content surrounding plaques in the cerebral cortex in the PSAPP mouse model of AA deposition. Our approach allowed us to measure fibrillar AA plaque content and an index of nonfibrillar AA species concurrently. We found that spine density was reduced within 6 Km of the plaque perimeter, remaining spines were more compact, and F-actin content per spine was increased. Measures of fibrillar AA plaque content were associated with reduced spine density near plaques, whereas measures of nonfibrillar AA species were associated with reduced spine density and size but not altered F-actin content. These findings suggest that strategies to preserve dendritic spines in AD patients may need to address both nonfibrillar and fibrillar forms of AA and that nonfibrillar AA may exert spine toxicity through pathways not mediated by depolymerization of F-actin.
INTRODUCTION
Alzheimer disease (AD) is the most common form of dementia and is characterized clinically by progressive loss of memory and cognitive function and progressive impairments in behavior. A number of neurodegenerative changes underlie these clinical manifestations. Two neuropathologic hallmarks of AD are extracellular amyloid plaques composed of amyloid-A (AA) peptide and intracellular neurofibrillary tangles, consisting of hyperphosphorylated microtubule-associated protein tau (1, 2) . Other pathologic changes include widespread cortical synapse loss, neuronal loss, and reactive gliosis (3) . Of these pathologic alterations, loss of synapses is the best structural correlate of cognitive impairments in AD (4, 5) . Genetic, in vitro, and in vivo studies have implicated soluble AA as a primary cause of the synapse loss in AD (6) .
In cerebral cortex, dendritic spines are the site of most excitatory synapses. Substantial evidence indicates that progressive loss of dendritic spines in AD is due to the effects of AA, either insoluble fibrillar AA deposited into amyloid plaques or nonfibrillar AA species lacking amyloid structure, the latter including soluble oligomers and protofibrils (7) . In organotypic slice culture, both exogenous exposure to soluble AA and overexpression of endogenous AA by neurons dramatically reduce dendritic spine density (8, 9) . Transcranial multiphoton imaging studies in transgenic mouse models of AD have shown that dendrites passing through or near fibrillar AA plaques undergo spine loss (10, 11) . Transgenic mouse model studies have also revealed that fibrillar AA plaques are surrounded by a halo of oligomeric AA and have reported a loss of excitatory synapses within this halo region (12) . Confocal microscopy in the PSAPP mouse model and in AD autopsy brain tissue has confirmed reduced densities of dendritic spines in proximity to fibrillar AA plaques (13) . Although informative, these studies did not address the relative contributions to dendritic spine loss of fibrillar AA in plaques and concurrently measured nonfibrillar (soluble) AA species.
Current understanding of dendritic spine maintenance and elimination has focused mainly on the regulation of the spine F-actin network. Long-term potentiation (LTP) is a form of activity-dependent synaptic plasticity that is widely believed to be the cellular basis for learning and memory. Enlargement of single spines has been shown to be associated with LTP (14) and requires polymerization of G-actin into F-actin (15) . Conversely, long-term depression (LTD), another form of activitydependent plasticity, has been shown to induce dendritic spine shrinkage and elimination via F-actin depolymerization (15Y17). Studies conducted in rodent hippocampus have demonstrated that soluble AA oligomers can enhance LTD and inhibit LTP, suggesting that AA-induced spine loss engages mechanisms that reduce F-actin content in spines (18, 19) .
In the present study, we used a novel multiple-label immunohistochemical approach in the PSAPP transgenic mouse model of AA deposition to measure spine density, size, and F-actin content surrounding plaques in the cerebral cortex. In addition, our approach allowed us to concurrently measure fibrillar AA plaque content and an index of nonfibrillar AA species, examining their relationship to spine parameters. We found that dendritic spine density was reduced and that the remaining spines were more compact within 6 Km of the plaque perimeter, with a concomitant increase in F-actin content per spine. Measures of fibrillar AA plaque content were associated with reduced spine density near plaques, whereas measures of nonfibrillar AA species were associated with reduced spine density, size, and shape complexity but not with altered F-actin content.
MATERIALS AND METHODS

Transgenic Animals
Double transgenic PSAPP mice were generated by mating male APP Tg2576 (K670N/M671L) mice (20) (Taconic Farms, Germantown, NY) with female M146L PS1 mice (mutant PS1, line 6.2, University of South Florida) (21) . The Tg 2576 mice were derived from a C57B6/SJL Â C57B6 background; the M146L PS1 animals were derived from a Swiss-Webster/B6D2F1 Â B6D2F1 background (22) . Food and water were available ad libitum, and a 12/12-hour light/ dark cycle was maintained. All studies were approved by the University of Pittsburgh Institutional Animal Care and Use Committee. All mice were male to circumvent concerns about the effects of estrous cycling on spine density.
Tissue Preparation and Immunohistochemistry
PSAPP mice were anesthetized with isoflurane and perfused transcardially with phosphate buffer followed by cold 4% paraformaldehyde. Brains were removed, immersion-fixed in cold 4% paraformaldehyde for 24 hours, and cryoprotected in a series of 15% and 30% sucrose solutions. Sections were cut coronally at 40 Km on a freezing sledge microtome and stored at j20-C in cryoprotectant solution (23) . A single section was selected for analysis from each of four 12-week-old, three 15-week-old, and four 18-week-old mice, matched for rostral-caudal level using cytoarchitectonic features (~bregma j2.30 mm [24] ).
Histochemical staining of fibrillar AA plaques was performed using X-34, a highly fluorescent Congo red derivative, which binds peptides and proteins in fibrillar AYpleated sheet conformations (''amyloid'') with a high affinity (25) . Because immunoreactivity of fibrillar AA plaques to anti-AA antibodies is weak unless a formic acid pretreatment is used to break up the fibrillar AYpleated sheet structure (25), we used 3 different antibodies, each in the absence of formic acid pretreatment, to visualize nonfibrillar AA. The 6E10 antibody (biotinylated, SIG-39340; Covance, Emeryville, CA) is directed against the Nterminus of human AA peptide. The 4G8 antibody (biotinylated, SIG-39240; Covance) is directed against AA amino acids 17 to 24. Western blot analyses provide clear evidence that 6E10 and 4G8 are reactive with soluble monomeric and oligomeric species of AA (26, 27) . Because both of these antibodies may crossreact with the AA precursor protein (APP), we also used the anti-AA x-40 antibody (AB5074P; Millipore, Temecula, CA), which is directed against the neo-epitope at amino acid 40 of the AA peptide and has human and mouse species reactivity. This antibody predominantly labels AA 1-40, and does not label longer AA forms (e.g. 1Y42) or full-length APP (28) . Histochemical staining of dendritic spines was accomplished with the F-actin-binding mushroom toxin phalloidin, conjugated to Alexa Fluor 568 (A12380; Invitrogen, Eugene, OR) (29) . Although a direct, linear relationship specifically between phalloidin fluorescence intensity and F-actin concentration has not been firmly established, we have previously shown that detected fluorescence intensity is directly related to the intensity of fluorescent microspheres embedded in thick sections and can be used to measure protein concentration accurately (30, 31) .
Free-floating tissue sections were incubated in 1% NaBH 4 for 30 minutes followed by a 3-hour incubation at room temperature in phosphate-buffered saline (PBS) containing 5% normal human serum, 5% goat serum, and 0.3% Triton X-100, and then incubated with PBS containing 5% normal human serum, 5% goat serum, and a 1:1000 dilution of biotinylated 6E10 antibody, a 1:1000 dilution of biotinylated 4G8 antibody, or a 1:100 dilution of anti-AA x-40 antibody for 24 hours at 4-C. Next tissue sections were incubated for 24 hours at 4-C in PBS containing 5% normal human serum, 5% goat serum, phalloidin conjugated to Alexa Fluor 568 at a concentration of 1.5 Kl/ml and either a 1:500 dilution of streptavidin conjugated to Alexa Fluor 488 (Invitrogen) or 1:500 goat anti-rabbit secondary antibody conjugated to Alexa Fluor 488 (Invitrogen). All tissue sections were then mounted on slides, and after drying for 1 hour, the sections were rehydrated for 5 minutes in PBS. Sections were incubated for 10 minutes in 100 Kmol/L stock solution of X-34 and then dipped in distilled water and incubated in 0.2% sodium hydroxide made in 80% unbuffered ethanol for 2 minutes; they were then soaked in distilled water for 10 minutes. Sections were coverslipped with Vectashield hard set (Vector Laboratories, Burlingame, CA). Final mean (SD) section thickness was 10.45 (4.409) Km. Sections were processed and analyzed in 2 separate immunohistochemistry runs.
Microscopy
Data acquisition was performed on an Olympus (Center Valley, PA) BX51 WI upright microscope equipped with an Olympus spinning disk confocal (SDCM) using an Olympus PlanAPO N 60Â 1.42 NA oil immersion objective. The SDCM was equipped with an ORCA-R2 camera (Hamamatsu, Bridgewater, NJ), MBF CX9000 front-mounted digital camera (MicroBrightField, Inc., Natick, MA), BioPrecision2 XYZ motorized stage with linear XYZ encoders (Ludl Electronic Products Ltd., Hawthorne, NY), excitation and emission filter wheels (Ludl Electronic Products Ltd.), and equipped with a Sedat Quad 89000 filter set (Chroma Technology Corp., Bellows Falls, VT). The microscope was controlled by Stereo Investigator Slidebook (Intelligent Imaging Innovations) software (MicroBrightField, Inc.) and illuminated using a Lumen 220 metal halide lamp (Prior Scientific, Rockland, MA).
Using Stereo Investigator software, the cerebral cortex of each tissue section was first outlined and a systematic random sampling grid was then randomly rotated and applied to each tissue section (Figure, Supplemental Digital Content 1, http://links.lww.com/NEN/A474). At each site, defined by the intersection of the grid with the cortical gray matter, the investigator determined if a visible single plaque (defined by the presence of X-34Ypositive staining) was present within the 512 Â 512 field of view at high power. When a single plaque was present, it was then recentered in the field of view and, if it fit within the 512 Â 512 pixels window of uniform fluorescence illumination, it was used for quantification, that is, an image stack was collected.
Each 3-dimensional image stack consisted of image planes of 512 Â 512 pixels (~3,058 Km 2 ) that were separated by 0.25 Km and acquired throughout the tissue section starting at the slide. At each plane, data were collected using the following filters: excitation 403 T 6 nm/emission 457 T 25 nm, excitation 490 T 10 nm/emission 528 T 19 nm, and excitation 555 T 14 nm/emission 617 nm T 37 nm. Exposure times (150, 1,000, and 1,100 seconds, respectively) were maintained for all experiments, and there were no instances of pixel saturation in any stack.
Image Processing
To control for differences in background fluorescence intensity across animals, sections, and image stacks, the mode , and fibrillar AA plaque (blue) (A1). The raw image was processed using the constrained iterative (CI) algorithm deconvolution for the AA-immunoreactivity (green) and fibrillar AA plaque (blue) and the Gaussian filter transformation for dendritic spines (red). Dendritic spines are now clearly defined punctate structures and the amyloid and AA-Immunoreactive structures are refined (A2). Generation of a binary mask (blue) using iterative threshold segmentation of the Gaussian filter transformation (red) from the image seen in (A2) shows the precision of dendritic spine coverage achieved using this processing technique. For extraction of relative fluorescence intensity within spines, the mask shown is overlaid on the CI deconvolved phalloidin channel (A3). (B1YB3) Three-dimensional shells surrounding a plaque. A single plane from a CI deconvolved image with dendritic spines (red), AA-immunoreactivity (green), and fibrillar AA plaque (blue) (B1). Outline of the first 4 (of 12) shells used in the analysis; each is expanded by 2 Km from the edge of the fibrillar AA plaque overlayed on (A) (B2). Three-dimensional surface rendering of lower half of the same image stack with a representative shell shown in dark blue (B3). of the histogram was identified and subtracted. The choice of this approach reflected several considerations. First, because labeled objects of interest (i.e. dendritic spines) represent a minority of the voxels, the modal value is reflective of the background. Second, this approach is without the potential for operator bias. Third, nonspecific background fluorescence is variable between sites and across samples (32) , particularly in tissue sections.
After background subtraction, the phalloidin channel was transformed to enhance automated detection of dendritic spines. Specifically, the final output was a subtraction of Gaussian filter channels of 2 different SDs of the Gaussian distribution
Digital Content 2, http://links.lww.com/NEN/A475 demonstrates this concept with a 500-nm fluorescent bead. Data segmentation of the Gaussian filter transformation of the phalloidin channel to create binary mask objects was performed as previously described (30) except that threshold settings were evenly spaced (50 gray levels; Fig. 1A ). This approach provides for quantification of large numbers of phalloidin-labeled objects, with little contribution of nonspecific fluorescent signal (Figure, Supplemental Digital Content 3, http://links.lww.com/NEN/A476). Image channels for nonfibrillar AA, fibrillar AA plaques, and phalloidin, but not the Gaussian filter transformation channel, were deconvolved using the constrained iterative algorithm included in SlideBook 5.13. After deconvolution, a region of interest containing the entire fibrillar AA plaque was manually defined, and a threshold segmentation set at 50 grayscale units above background was applied to the X-34 channel intensity to generate a binary mask object of the plaque. Twelve contiguous 3-dimensional concentric shells were constructed around the outer edge of the fibrillar AA plaque (Fig. 1B) . Each shell was created using the mask dilation command in SlideBook, which allowed each shell mask, starting with the mask of the plaque, to be increased in radial size by exactly 2 Km from the prior mask. The prior mask was then subtracted from this larger mask to create each shell. The coordinates of the centroid for each phalloidin channel mask object were used to assign each mask object to a single shell, allowing for the analysis of dendritic spine density, morphology, and relative fluorescence intensity at known distances from the fibrillar AA plaque.
Statistical Methods
Initial comparison of spine parameters as a function of distance (0Y6 and 96 Km) from the fibrillar AA plaque for the 134 measured plaques used linear mixed models with a firstorder autoregressive covariance structure. Subject-level effects were animal, with repeated measures of plaque and shell. Fixed effects were fibrillar AA plaque volume, mean X-34 fluorescence intensity within the plaque, total nonfibrillar AA intensity within the shell, immunohistochemistry run, and (to control for any possible effects of the small difference in ages between mice) age group. For the analysis of the impact of plaque and nonfibrillar AA effects on dendritic spine density, linear mixed models with a first-order autoregressive covariance structure were used to analyze each concentric shell. Plaque was a repeated measure within animal, with fixed effects of fibrillar AA plaque volume, mean X-34 fluorescence intensity within the plaque, total nonfibrillar AA intensity within the shell, immunohistochemistry run, and age group. Spine density in each shell, that is, at each distance from the plaque, was the dependent variable. Based on the results of the preceding linear mixed models, further analyses of spine density, morphology and total F-actin content per spine were conducted for shells within 0 to 6 Km of the plaque perimeter. These analyses used mixed models, with repeated measures within animals of plaque and shell, and fixed effects of fibrillar AA plaque volume, mean X-34 fluorescence intensity within the plaque, total nonfibrillar AA intensity within each shell, immunohistochemistry run, and age group. Additional models in which final section thickness was entered to evaluate whether section shrinkage during processing might have influenced the associations did not alter the results except where indicated. All intensity measurements used in the analyses were normalized across immunohistochemistry run to account for assay variability.
RESULTS
Detection of AA-Immunoreactivity Surrounding Fibrillar AA Plaques
Anti-AA antibodies 6E10, 4G8, and anti-AA x-40 revealed a similar pattern of label concentrated in the immediate surrounding area of the X-34Ypositive fibrillar AA plaque ( Fig. 2A) . Three-dimensional surface renderings also demonstrated accumulation of AA-immunoreactivity around X-34Ypositive fibrillar AA plaques (Fig. 2B) . (Fig. 4) . Quantitative analyses of a total of 830,634 spines in the PSAPP mouse cortex confirmed that spine density was lower within this 6-Km perimeter of the AA plaque ( Fig. 4 ; Table 1 ). In contrast, we analyzed spine densities in 16-week-old male C57BL6/J mice (Figure, Supplemental Digital Content 5, http://links.lww.com/NEN/A478). A phantom plaque was created in the middle of each image stack, and 12 concentric shells were constructed as in the PSAPP mice and spine densities were calculated. There was no significant difference of spine density between any of the shells in the C57BL6/J mice.
In addition to reductions in spine density within the 6-Km perimeter of the AA plaque, spine volume was lower in this region and spine surface area was reduced, resulting in a reduction in spine shape complexity (Table 1) . Despite these changes in spine morphology, there was no decrease in total phalloidin intensity per spine. In fact, there was a significant increase in these values within the 6-Km perimeter, indicating an increased concentration of F-actin within these spines. Table 2 . Linear mixed models showed that a decrease in spine density was independently associated with greater fibrillar AA plaque mean X-34 fluorescence intensity the first 6 Km from the plaque and with greater total AA-immunoreactivity (6E10 fluorescence intensity) within the first 2 Km of the plaque edge (Table 2 ; Fig. 4) . No significant effect was seen because of fibrillar AA plaque volume.
Decreases in spine volume and surface area were significantly associated with nonfibrillar AA 6E10 fluorescence intensity within 6 Km of the fibrillar AA plaque edge (Table 3) . Interestingly, the relative amount of F-actin as indexed by phalloidin fluorescence intensity measured per spine did not change as a function of AA-immunoreactivity (Table 3 ). There were no significant associations of fibrillar AA plaque mean X-34 fluorescence intensity with spine morphology or relative amount of F-actin. 
DISCUSSION Spine Density and Morphology Alterations are Present Surrounding Fibrillar AA Plaques
We observed significant decreases in spine density within the first 6 Km beyond the perimeter of fibrillar AA plaque because of independent contributions of fibrillar AA plaque content and content of AA-immunoreactivity. A study by Spires et al (10) using 21-to 25-month-old Tg2576 mice similarly reported that distance from plaque perimeter correlates with deficits in spine density. In that study, plaque area (similar to plaque volume in the current report) was also not correlated with spine loss (10); however, the investigators found that the correlation between distance from the plaque and reduced spine density extended up to 20 Km. This discrepancy likely reflects the differences in mouse strain, in the ages and degree of plaque pathology of these animals, and/or differences in imaging methods between that and the current study.
In addition to reductions in spine density, we found decreases in surface area and shape complexity and a trend toward decreased spine volume surrounding plaques. These findings suggest that spine physiology could be altered even before their disappearance. Soluble AA species have been shown to engage LTD and inhibit LTP pathways (18, 19) , processes that typically lead to spine loss via spine F-actin depolymerization (15) . It was therefore somewhat surprising that when investigating the relative amount of F-actin, as indexed by total phalloidin fluorescence measured per spine, we did not observe net reductions in spines close to plaques. In fact, we saw an increase in phalloidin total intensity within smaller, more spherical spines. Thus, the mechanism of spine morphology changes does not seem to be through net depletion of F-actin but through restructuring of the cytoarchitecture.
Actin filaments in the spine head are very dynamic, and there are several mechanisms by which actin polymerization and depolymerization are regulated to influence the spatial arrangement of F-actin in spines. For example Arp2/3 binds to existing actin filaments to nucleate new filaments and facilitate branching (33) . Another actin-regulating molecule, myosin II, binds and contracts actin filaments and is required for proper spine morphology (34) . Drebrin is an actin-binding protein localized in spines that is thought to inhibit the actin-myosin interaction and subsequently alter spine morphology (35) . Still other proteins, such as cofilin, are responsible for proper spine head morphology, play an active role in actin dynamics (36) , and result in pathologic changes in actin in response to soluble AA (37). Thus, one or more of these molecular mechanisms may be acting to alter spine morphology in a manner independent of F-actin loss.
Relative Contributions of Fibrillar and Nonfibrillar AA Species to Spine Alterations Surrounding Fibrillar AA Plaques
Previous in vitro studies with synthetic AA have reported that fibrillar AA forms, such as those found in AA plaques, are neurotoxic (38, 39) . Other studies have implicated soluble AA as the primary contributor to synaptotoxicity (40, 41) . Because both forms can exist in equilibrium, there is some controversy regarding which is primarily responsible for pathologic effects (26) . We observed a halo of AA immunoreactivity in the immediate surround of the X-34Ypositive fibrillar AA plaque. We interpret this AA-immunoreactivity as an index enriched for the content of nonfibrillar soluble AA species in the plaque surround. This interpretation is based on several aspects of our approach and findings. Although the 3 antibodies used in the present study target different portions of the AA peptide (i.e. the N-terminus, midportion, and C-terminus), they produced comparable patterns of AA immunoreactivity around the X-34Ypositive fibrillar AA plaque, which suggests that we are in fact labeling AA forms rather than full-length APP (which is not detected by anti-AA x-40 ) or another related metabolic fragment. Second, there is clear evidence that at least antibodies 6E10 and 4G8 label nonfibrillar soluble species of AA (26, 27) . Third, soluble AA binds locally to synaptic structures (12) and to various components of the extracellular matrix (42) , either of which would facilitate in situ fixation, although some nonfibrillar soluble AA would likely be lost by diffusion. Fourth, in the absence of formic acid pretreatment, we saw little evidence of colocalization of anti-AA labeling with X-34 staining, the latter of which is highly selective for fibrillar, A-pleated sheet conformations (25) . Whereas some anti-AA binding to fibrillar AA in plaques may still occur, our approach would have enriched the relative contribution of nonfibrillar AA species to the total measured AA-immunoreactivity. Fifth, we observed effects likely to reflect the toxicity of AA at distances up to 6 Km beyond the edge of the fibrillar AA plaque, consistent with diffusion of soluble species. The interpretation that AA-immunoreactivity indexes nonfibrillar AA species is also consistent with the observed dissociation of AA-immunoreactivity and fibrillar AA plaque content with measures of spine morphology, in contrast to the finding that each is associated with spine loss. This dissociation suggests that fibrillar and nonfibrillar AA may lead to spine loss via distinct pathways. For example, dendrites passing through or near fibrillar AA plaques demonstrate a number of abnormalities, including atrophy, tortuosity, varicosities, and local loss of spines in the affected segments (13, 10) . Thus, fibrillar AA plaques may lead to spine loss via toxic effects on dendrites, perhaps via effects on tau, which accumulates in dendrites, and can interfere with microtubule functions necessary for spine growth and maintenance (43, 44) . In contrast, soluble AA species have been shown to bind directly to synaptic structures and may induce spine loss by altering postsynaptic signal transduction pathways (12, 18) .
Potential Limitations of this Study
Because fibrillar and nonfibrillar AA exist in equilibrium, there may be no in vivo (or in vitro) approach that can conclusively determine their independent effects when both are concurrently present. However, our data are consistent with a model in which AA fibrils in plaques are themselves toxic to spines and serve as a reservoir for toxic soluble forms of nonfibrillar AA, with a concentration gradient that falls with distance from the plaque edge. Transgenic mouse models aspire to capture some or all aspects of often uniquely human diseases, such as AD. The PSAPP mouse model demonstrates robust amyloid plaque deposition, well-characterized synaptic loss, and cognitive deficits that correlate with presence of oligomeric AA species (45) , making it an excellent model to examine effects resulting from AA accumulation, a process that seems to correspond to the earliest stages of AD (46) . However, the PSAPP model lacks the neurofibrillary tangle formation and neuronal loss that are seen as AD progresses (45) . This discrepancy between the PSAPP model and human neuropathology enhance confidence in the interpretation that our findings are secondary to AA but render uncertain whether the associations identified in the current study are ultimately present in humans. This could be addressed by extending our multiple wavelength imaging and quantification approach to human postmortem tissue, but this application is not straightforward because of tissue autofluorescence and high plaque densities in AD tissue.
Another potential limitation to this study derives from our approach to spine imaging. We used phalloidin labeling to estimate spine volume, surface area, and shape. Electron microscopy studies have shown that actin is the major cytoskeleton component in spines and plays a pivotal role in spine size and shape (47) . Thus, phalloidin labeling presents a good overall estimate of spine shape and size; however, dendritic spines also contain other components, such as postsynaptic machinery and membrane-bound organelles, which contribute to their shape and volume to some degree (48) . We imaged our sections via SDCM. This approach has several advantages relative to other fluorescent imaging methods for quantification in synaptic structures (49) . Nevertheless, our approach shares with other confocal techniques limitations in z-axis resolution. Whereas this limitation is mitigated by the Gaussian filter transformation we applied during image processing, it may still have caused us to underestimate spine density by failing to discriminate spines closely apposed in the z-axis. Because we found reduced density of spines in the same region where spines were more compact, any such potential limitation would have biased against our detected effect rather than having contributed to it. Moreover, whereas alternate techniques such as array tomography may enhance z-axis resolution, they suffer from the same disadvantages for fluorescence intensity quantification (relative to spinning disk) as we have described for other laser scanning confocal techniques (49) .
Finally, our working assumption was that amyloid plaques are embedded randomly throughout all parenchymal structures and thus sampled a large number of plaques. However, reduced spine density could be due to cell bodies around plaques if plaques preferentially form in areas of high cell body density.
Implications for AD
Accepting the caveats associated with the PSAPP model discussed above, our findings have significance for therapeutic strategies in AD. We found that dendritic spine degeneration and loss in cerebral cortex were independently associated with both fibrillar AA plaque content and with an index of nonfibrillar, presumptively soluble, AA species. These findings argue strongly that therapeutic strategies should consider targeting both forms of AA concurrently. In addition, the novel findings that spine morphology was altered in relation to an index of nonfibrillar AA content, but not associated with reduced relative F-actin content per spine, suggest an effect of nonfibrillar AA on pathways that signal to actin-regulating molecules outside canonical LTD pathways. The specific pathways remain to be elucidated and may represent novel targets for therapy for AD.
